FDA inspection

Regeneron Pharmaceuticals Inc: FDA inspection ending Jan 19, 2024

FDA inspection 1228712 · No Action Indicated (NAI) · Tarrytown, NY

Key facts

Inspection ID 1228712
Firm Regeneron Pharmaceuticals Inc
FEI number 1000521995
Address 777 Old Saw Mill River Rd
City Tarrytown
State NY
ZIP 10591
Country United States
Fiscal year 2024
Inspection end date Jan 19, 2024
Classification No Action Indicated (NAI)
Project area Bioresearch Monitoring
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections